When periprocedural MI was excluded , the efficacy of prasugrel remained consistent among primary and secondary PCI patients at @ days ( HR : @ ; @ % CI : @ to @ vs. HR : @ ; @ % CI : @ to @ ; p interaction = @ ) and @ months ( HR : @ ; @ % CI : @ to @ vs. HR : @ ; @ % CI : @ to @ ; p interaction = @ ) .